Detoxifying capacity and kinetics of the molecular adsorbent recycling system - Contribution of the different inbuilt filters

被引:33
作者
Evenepoel, P [1 ]
Maes, B [1 ]
Wilmer, A [1 ]
Nevens, F [1 ]
Fevery, J [1 ]
Kuypers, D [1 ]
Bammens, B [1 ]
Vanrenterghem, Y [1 ]
机构
[1] Univ Hosp Leuven, Dept Med, Div Nephrol, Louvain, Belgium
关键词
liver failure; albumin dialysis; albumin-bound toxins;
D O I
10.1159/000070697
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular adsorbent recycling system (MARS) represents a cell-free, extracorporeal, liver assistance method for the removal of both albumin-bound and water-soluble endogenous toxins. The aim of the present study was to evaluate the short- and long-term removal capacity and selectivity of the different inbuilt dialysers and adsorption columns (uncoated charcoal, anion exchanger resin). Levels of endogenous toxins and parameters of hepatic synthesis and necrosis were therefore monitored before, during and after the MARS treatment phase in 10 patients. Moreover, blood and dialysate clearances of urea, creatinine, bilirubin and bile acids were determined during a single treatment. The significant increasing time course of total bilirubin blood levels before the start of the treatment could be stopped and reversed in a significant decreasing time course. The removal rates of urea nitrogen, bilirubin and bile acids during a single treatment amounted to 55.5 +/- 4.0, 28.3 +/- 3.9, and 55.4 +/- 4.0% (mean +/- SEM), respectively. The efficacy of removal of albumin-bound toxins sharply declined early after initiation of the treatment to become negligible after 6 h. In conclusion, both albumin-bound and water-soluble toxins are adequately removed by the MARS. Our data suggest that the rate and efficacy of removal of albumin-bound toxins are related to both the strength of the albumin binding and the saturation of the adsorption columns. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 27 条
[1]  
Ash SR, 2001, AM J KIDNEY DIS, V38, P219
[2]   Results of a phase I trial evaluating a liver support device utilizing albumin dialysis [J].
Awad, SS ;
Swaniker, F ;
Magee, J ;
Punch, J ;
Bartlett, RH .
SURGERY, 2001, 130 (02) :354-362
[3]   Sieving coefficient inaccuracies during hemodiafiltration in patients with hyperbilirubinemia [J].
Chadha, V ;
Garg, U ;
Warady, BA ;
Alon, US .
PEDIATRIC NEPHROLOGY, 2000, 15 (1-2) :33-35
[4]   Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances [J].
Falkenhagen, D ;
Strobl, W ;
Vogt, G ;
Schrefl, A ;
Linsberger, I ;
Gerner, FJ ;
Schoenhofen, M .
ARTIFICIAL ORGANS, 1999, 23 (01) :81-86
[5]   Acute liver failure [J].
Gill, RQ ;
Sterling, RK .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (03) :191-198
[6]  
Klammt S, 2001, Z Gastroenterol, V39 Suppl 2, P24, DOI 10.1055/s-2001-919056
[7]   Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy [J].
Kramer, L ;
Gendo, A ;
Madl, C ;
Ferrara, I ;
Funk, G ;
Schenk, P ;
Sunder-Plassmann, G ;
Hörl, WH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (06) :1193-1200
[8]   Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins [J].
Kreymann, B ;
Seige, M ;
Schweigart, U ;
Kopp, KF ;
Classen, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (06) :1080-1085
[9]   Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane [J].
Lesaffer, G ;
De Smet, R ;
Lameire, N ;
Dhondt, A ;
Duym, P ;
Vanholder, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (01) :50-57
[10]  
Mamianetti A, 2000, CLIN NEPHROL, V53, P194